SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-004564
Filing Date
2019-03-08
Accepted
2019-03-08 07:02:35
Documents
4
Period of Report
2019-03-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT s002621x24_8k.htm 8-K 48533
2 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CELGENE CO s002621x24_ex23-1.htm EX-23.1 5083
3 THE HISTORICAL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENT s002621x24_ex99-1.htm EX-99.1 2959867
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF BRISTOL-MYERS SQ s002621x24_ex99-2.htm EX-99.2 340002
  Complete submission text file 0001140361-19-004564.txt   3354673
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 19667584
SIC: 2834 Pharmaceutical Preparations